New obesity drug, Meridia (sibutramine)

March 1998

    There's lots of interest in Knoll's new obesity drug, Meridia (sibutramine).

    Knoll just starting shipping it in the U.S....they've also applied to market it in Canada.

    Meridia is an appetite suppressant. It works by inhibiting the reuptake of norepinephrine...serotonin...and to a lesser extent, dopamine.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote